Bleeding from the gut while on blood thinners
Part of Digestive system clinical trials.
This study collects information from patients who come to the emergency room with gastrointestinal bleeding while taking certain newer blood thinners. It aims to better understand and manage this type of bleeding.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You are coming to the emergency room because of bleeding in your digestive tract (such as vomiting blood, black stool, or bright red blood from the rectum).
- You take a newer blood thinner called dabigatran (Pradaxa), apixaban (Eliquis), or rivaroxaban (Xarelto).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how often a stool test for hidden blood becomes positive in people who are taking blood thinners. It may help doctors understand how these medicines affect the test results.
This study looks at how to safely restart blood thinners after a major gastrointestinal bleed, specifically for people with atrial fibrillation or blood clots. It aims to find the best timing and approach to prevent future strokes or clots while avoiding another bleed.
This study looks at side effects of blood thinners (anticoagulants) in patients who visited the emergency department. It helps doctors understand how to better manage these medications.
This study looks at patients with heart disease who take antiplatelet drugs (like aspirin or clopidogrel) and then develop bleeding in the stomach or intestines. The goal is to understand and improve care for this bleeding while managing heart disease.
This study compares bleeding after common endoscopic procedures (like colonoscopy or upper endoscopy) between people who take blood thinners and those who don't. It may help doctors better understand risks for patients on anticoagulants.
This study looks at patients who develop bleeding in the stomach or intestines while in the intensive care unit (ICU). It aims to understand how common this is and what factors might be involved, which could help improve care for future patients.
Hear when a new Gastrointestinal Bleeding trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.